Dongwha Pharm.Co.,Ltd (KRX: 000020)
South Korea
· Delayed Price · Currency is KRW
6,290.00
-80.00 (-1.26%)
Dec 20, 2024, 3:30 PM KST
Dongwha Pharm.Co.,Ltd Company Description
Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea.
It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics.
The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.
Dongwha Pharm.Co.,Ltd
Country | South Korea |
Founded | 1897 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 816 |
Contact Details
Address: FastFive Tower Seoul, 04522 South Korea | |
Phone | 82 2 2021 9300 |
Website | dong-wha.co.kr |
Stock Details
Ticker Symbol | 000020 |
Exchange | Korea Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | KRW |
ISIN Number | KR7000020008 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Chang-Soo Cho | Co-Chief Executive Officer and President |
Doh Joon Yoon | Chairman of the Board and Co-Chief Executive Officer |